Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Impact of COVID-19 on Gastroenterology Fellowship Training].
Shin HP, Cha JM, Kim BK, Myung DS, Moon SH, Song MJ, Yoon SB, Yoo IK, Lee JH, Jun BG, Hyun JJ; Education Committee of the Korean Society of Gastroenterology. Shin HP, et al. Among authors: kim bk. Korean J Gastroenterol. 2021 May 25;77(5):205-213. doi: 10.4166/kjg.2021.049. Korean J Gastroenterol. 2021. PMID: 34035196 Free article. Korean.
Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study.
Hyun HK, Cho EJ, Park SY, Hong YM, Kim SS, Kim HY, Heo NY, Park JG, Sinn DH, Kang W, Jeong SW, Song MJ, Park H, Lee D, Lee YS, Cho SB, An CS, Rhee HJ, Lee HW, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Lee JH, Yu SJ, Kim YJ, Yoon JH, Tak WY, Kweon YO, Yoon KT, Cho M, Cheong JY, Park SH, Kim SU; Korean TACE Study Group. Hyun HK, et al. Among authors: kim ss, kim hy, kim yj, kim su, kim dy, kim bk. Dig Dis Sci. 2021 Jul;66(7):2427-2438. doi: 10.1007/s10620-020-06533-7. Epub 2020 Aug 28. Dig Dis Sci. 2021. PMID: 32856240
Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: a Korean multicenter study.
Lee S, Kim BK, Kim SU, Park SY, Kim JK, Lee HW, Park JY, Kim DY, Ahn SH, Tak WY, Kweon YO, Lee JI, Lee KS, Kim HJ, Han KH. Lee S, et al. Among authors: kim jk, kim su, kim hj, kim dy, kim bk. J Gastroenterol Hepatol. 2014;29(7):1463-9. doi: 10.1111/jgh.12542. J Gastroenterol Hepatol. 2014. PMID: 25273508
2,209 results